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ABSTRACT

This disclosure describes a MRI-compatible bioreactor that
allows a biological sample to be imaged in culture without
disrupting or compromising the culture.
18 Claims, 2 Drawing Sheets
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Temp and CO2 Sensor Output Within 12 Hours
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MR-COMPATIBLE BOREACTORS AND
METHODS OF USING

communication between the at least one reservoir and the

culture media in the Support chamber.
In some embodiments, a MRI-compatible bioreactor sys
tem further can include a microcontroller. A microcontroller

CROSS REFERENCE TO RELATED
APPLICATIONS

This application claims the benefit of priority under 35
U.S.C. S 119(e) to U.S. Application No. 61/677,039 filed Jul.
30, 2012. The prior application is incorporated herein by
reference in its entirety.
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TECHNICAL FIELD

This disclosure generally relates to bioreactors and, more
specifically, MRI-compatible bioreactors, and methods of
using Such bioreactors.

15

BACKGROUND

Magnetic resonance imaging (MRI) can observe structural
and functional changes associated with cell and tissue devel
opment, facilitating the use of MRI in translational research
and clinical trials of tissue engineering. One problem when
applying MRI to tissue engineering is that samples allocated
in a test tube for imaging cannot be returned back to incuba
tors and are, therefore, wasted due to potential contamination.
In addition, Samples removed from the incubator for imaging
and, therefore, are not under consistent growth conditions or
environments. Thus, there is a need for an approach that
allows the functional outcome of cellor tissue constructs to be
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can be in communication with the at least one fiber optic
sensor, with the heater, or with the at least one fiber optic
sensor and the heater, where the at least one fiber optic sensor
is a temperature sensor.
In another aspect, a method of imaging a biological sample
is provided. Such a method typically includes providing a
MRI-compatible bioreactor system as described herein,
where the tissue imaging chamber comprises a biological
sample and the Support chamber comprises culture media;
inserting at least the tissue imaging chamber of the bioreactor
component into a MR imager such that the tissue imaging
chamber falls within the field-of-view (FOV) of the MR
imager and the support chamber does not fall within the FOV
of the MR imager; and imaging the biological sample using
the MR imager.
The MRI-compatible bioreactor described herein can be
inserted into the MR imager and imaged without disrupting
the biological sample. In some embodiments, the methods
include repeating the inserting and imaging steps at least
twice, where repeating the inserting and the imaging steps at
least twice does not require removing the biological sample or
any portion thereof from the bioreactor and does not compro
mise the biological sample or the culture media. In some
embodiments, the methods include repeating the imaging
step at least twice, where the inserting step is performed only

monitored non-invasively without interrupting or disturbing

OCC.

the culture.

In some embodiments, the methods also include exchang
ing the media in the support chamber with fresh media in the

SUMMARY

at least one reservoir via the fluidics. In some embodiments,
35

This disclosure describes a MRI-compatible bioreactor,
which allows imaging of a growing biological sample without
disrupting or disturbing the culture.
In one aspect, a MRI-compatible bioreactor system is pro
vided. Such a system generally includes a bioreactor compo
nent that includes a tissue-imaging chamber and a Support
chamber. The tissue-imaging chamber and the Support cham
ber generally are separated by a permeable Support that

40

Unless otherwise defined, all technical and scientific terms

45

used herein have the same meaning as commonly understood
by one of ordinary skill in the art to which the methods and
compositions of matter belong. Although methods and mate
rials similar or equivalent to those described herein can be
used in the practice or testing of the methods and composi

50

below. In addition, the materials, methods, and examples are
illustrative only and not intended to be limiting. All publica
tions, patent applications, patents, and other references men
tioned herein are incorporated by reference in their entirety.

allows for fluid communication between the chambers. At

least the tissue-imaging chamber of the bioreactor component
is configured to be received within a magnetic resonance
(MR) imager and includes at least one fiber optic sensor and
fluidics capable of fluidly communicating with a source of
oxygen. The Support chamber generally includes a heating
element and fluidics capable offluidly communicating with at
least one reservoir, where the Support chamber is configured
to be able to comprise culture media and maintain the culture

the methods further include repeating the exchanging step at
least twice separated by a period of time. Periods of time can
be, for example, hours, days, weeks, or months.
As used herein, the biological sample refers to a tissue
sample or a cell sample.

tions of matter, suitable methods and materials are described

DESCRIPTION OF DRAWINGS

media under Suitable conditions.

As described herein, the tissue imaging chamber is config
ured to fall within the field-of-view (FOV) of the MR imager,
and the support chamber is configured to fall outside the FOV
of the MR imager.
In some embodiments, the at least one fiber optic sensor is
a temperature sensor. In some embodiments, the at least one
fiber optic sensor is a CO2 sensor and/or a humidity sensor. In
Some embodiments, the Support chamber further includes at
least one non-fiber optic sensor. Representative non-fiber
optic sensors include, for example, temperature sensors and/
or pH sensors. In some embodiments, the at least one non
fiber optic sensor is in communication with a microcontroller.
In some embodiments, the MRI-compatible bioreactor
system further includes a pump configured to promote fluid
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FIG. 1 shows a schematic of a representative MRI-com
patible e-incubator.
FIG. 2 shows the preliminary results of culturing osteo
genic constructs in the e-incubator. Panel (a) shows an axial
MRI of the chamber system, a 1.1 cm inner diameter tissue
holder inside a 2.3 cm inner diameter TI chamber. Panel (b)
and Panel (c) show axial MRIs at week-1 and week-2, respec
tively, acquired by a fast spin-echo sequence with the same
acquisition parameters; the in-plane resolution was 97 micron
square. The construct position was slightly different from
week-1 to week-2 due to media exchange. Panel (d) is a graph
showing the 12-hour time course oftemperature (between 36
to 37°C.) and CO (5%), where the sharp drops represent the
event of media exchange every 6 hours.

US 9,051,541 B2
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Like reference symbols in the various drawings indicate
like elements.
DETAILED DESCRIPTION
5

The design of the MRI-compatible bioreactor described
herein is highly innovative. With an MRI-compatible cham
ber designed for culturing cells and tissue, the bioreactor
described herein is designed to integrate with a commercial
MR imager, which can be used to assess the morphogenesis of
developing tissue.
Conventional tissue culture bioreactors typically restrict
the ability to apply non-invasive medical imaging modalities.
Hollow fiber bioreactors (HFBRs) are the only MRI-compat
ible culture system (see, for example, Planchamp et al., 2004,
Biotechnol. Bioeng, 85:656-65). However, HFBRs are lim
ited by their lack of consistent physiological conditions inside
HFBRs due to, for example, their requirement for constant
media perfusion. In addition, conditions within HFBRs are
not detectable or easily regulated during MRI acquisition; for
example, in HFBRs, temperature is measured outside the
magnet, which is not a faithful representation of the cells or
tissues direct Surroundings.
Compared to existing methodologies, the MRI-compatible
bioreactor described herein offers an integrated approach that
takes full advantage of high-resolution MRI, currently, the
most Sophisticated clinically-viable imaging technique, by
enabling dynamic assessment of developing constructs in a
self-regulated and maintained culture environment.
FIG. 1 shows one embodiment of a MRI-compatible biore
actor system 1 as described herein. An MRI-compatible
bioreactor system 1 includes a bioreactor 10. As used herein,
a bioreactor (or bioreactor component) 10 refers to a device
that Supports and maintains the viability of cells or tissues in
culture and, in some instances, promotes the biological
growth and/or development of the cells or tissues. In the
embodiment shown in FIG. 1, the bioreactor component 10 is
cylindrical, although any shape that a MR imager is capable
of receiving is included herein. The bioreactor component 10
can be divided into a tissue-imaging chamber 12 and a Sup
port chamber 14, which are separated by a permeable Support
structure 16. The permeable support structure 16 is one that
allows for fluid communication between the tissue-imaging
chamber 12 and the support chamber 14.
In some embodiments, the tissue-imaging chamber 12 of
the bioreactor component 10 is configured to be received
within a magnetic resonance (MR) imager 50, while, in some
embodiments, the entire bioreactor component 10 is config
ured to be received within a MR imager 50. Even when the
entire bioreactor component 10 is to be inserted within a MR
imager 50, the tissue imaging chamber 12 is configured to fall
within the field-of-view (FOV) of the MR imager 50, while
the support chamber 14 is configured to fall outside the FOV
of the MR imager 50. As such, the tissue-imaging chamber 12
generally includes at least one fiber optic sensor 18, which is
compatible with FOV MR imaging, while the support cham
ber generally includes the culture media, which, as indicated
herein, is in fluid communication with the tissue-imaging
chamber 12 via the permeable support structure 16, a heating
element 20 to maintain the proper temperature of the culture

can include at least two reservoirs 24; at least one reservoir
24a to contain fresh media and at least one reservoir 24b to
10
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receive used or spent media during media exchange. In addi
tion, to facilitate media exchange, a MRI-compatible biore
actor system 1 optionally can include one or more pumps 26.
In some embodiments, the at least one fiber optic sensor 18
in the tissue-imaging chamber 12 is a temperature sensor.
Having a temperature sensor in the tissue-imaging chamber
12 allows for the temperature to be monitored, and modified
if necessary, during all aspects of cell or tissue growth includ
ing, for example, during the actual imaging. In addition or as
an alternative to a temperature sensor, the fiber optic sensor 18
in the tissue-imaging chamber 12 can be a CO sensor 28
and/or a humidity sensor. In addition, a tissue-imaging cham
ber 12 of a MRI-compatible bioreactor system 1 can include
fluidics 30 for maintaining and/or changing the environment
within the bioreactor. For example, fluidics 30 can connect
the tissue-imaging chamber 12 with an appropriate source of
air 32 (e.g., oxygen (O) and/or carbon dioxide (CO)) So as
to properly oxygenate the culture.
In some embodiments, the Support chamber 14 also
includes at least one sensor 34. Since the Support chamber is
configured to fall outside of the MRI FOV, sensors 34 that are
located in the support chamber 14 do not need to be fiber
optic. A sensor 34 located in the support chamber 14 can be,
for example, a pH sensor and/or a temperature sensor.
Since the bioreactor component of the MRI-compatible
bioreactor system is configured to fit inside a MR imager and
be imaged continually or at particular intervals, it would be
understood by those skilled in the art that the components in
the system that communicate and Support the bioreactor Such
as, without limitation, an appropriate source of oxygen, one
or more reservoirs, and/or one or more pumps, are exterior to
the bioreactor component but remain in fluid communication
with the bioreactor component via fluidics whether the biore
actor component is inside or outside the imager.
To sense and change the environment as necessary, a MRI
compatible bioreactor system 1 as described herein also can
include one or more microcontrollers 36. The one or more

50
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microcontrollers 36 can be in communication, for example,
with the one or more fiber optic sensors 18 in the tissue
imaging chamber 12 and/or with the heating element 20 and
fluidics 22 in the support chamber 14. In embodiments in
which the fiber optic sensor 18 in the tissue-imaging chamber
12 is a temperature sensor, the microcontroller 36 also can be
in communication with the heating element 20 in the Support
chamber 14, such that the temperature of the culture media
can be controlled and changed, as necessary or desired. In
addition, a microcontroller 36 can be in communication with

60

media, and fluidics 22 to be able to maintain the culture media
under Suitable conditions.

It would be understood that a heating element 20 in the
support chamber 14 needs to be compatible with MR imag
ing, but, since it falls outside of the FOV, does not need to be
compatible with the actual imaging. Therefore, an example of
a suitable heating element 20 is a ceramic heater. It would also

4
be understood that fluidics typically refers to at least some
form of tubing that is capable of fluidly communicating with
one or more components. In a MRI-compatible bioreactor
system 1, fluidics 22 associated with the support chamber 14
connect the support chamber 14 with at least one reservoir 24
(e.g., to receive, provide, and/or exchange culture media). In
some embodiments, a MRI-compatible bioreactor system 1

65

any additional sensors (e.g., fiber optic or non-fiber optic
sensors) used to sense and/or control the environment in the
bioreactor component 10. Further, a microcontroller 36 can
be used in the process of media exchange (e.g., between the
support chamber 14 of a bioreactor component 10 and one or
more reservoirs 24 via, for example, one or more pumps 26).
Conventionally, bone constructs are cultured in a CO
incubator, which provides a Suitable environment maintained
with respect to temperature, oxygen availability, and relative
humidity. The MRI-compatible bioreactor system 1
described herein is not just a replacement for conventional

US 9,051,541 B2
5
incubators that includes automated media exchange, but the
system described herein also offers a unique MR compatibil
ity. The MRI-compatible bioreactor system 1 described
herein provides a closely monitored and tightly controlled
physiological environment for developing cell or tissue con
structs inside an MRI, with continuous non-invasive assess

ment of the morphogenesis evolution and functional outcome
of the cell or tissue constructs through MRI.
In the current design, MRI compatibility was incorporated
because it is the most Sophisticated, clinically-viable, imag
ing technique. With proper adjustments, the design can be
modified to accommodate other imaging modalities such as
Computed Tomography (CT).
An MRI-compatible bioreactor system 1 as described
herein can be used to image a biological sample growing in
culture. Initially, a biological sample is deposited onto the
permeable Support structure 16 and appropriate culture con
ditions are established in the bioreactor 10. Appropriate cul

10

15

ture conditions are known to those skilled in the art and

typically include a culture media that provides the necessary
components to keep alive the cells or tissues (e.g., required
minerals, essential nutrients). The culture media also can
provide one or more co-factors required by the cells or tissues.
Appropriate culture conditions also include maintaining a
proper temperature range and pH range.
Appropriate culture conditions require that the culture
media be changed periodically. For example, the spent media
typically is replaced with fresh media so as to continue to
Support the growth of the culture. The rate of media exchange
is dependent upon the rate of growth of a particular organism
or organisms but, under typical culture conditions, media is
usually exchanged several times a day (e.g., every 2, 4, 6, 8 or
10 hours), twice a day (e.g., about every 12 hours), at least
once a day (e.g., every 18, 20, 22 or 24 hours), or more (e.g.,
every 30, 40 or 50 hours). In certain instances, the culture
media in a bioreactor can be exchanged on a weekly basis or
on a monthly basis.
In Some embodiments, a feedback system can maintain the
CO level in the tissue-imaging chamber using two flow con
trollers to mix CO, and airbased on the value recorded by the
CO sensor positioned on the output flow from the tissue
imaging chamber. In addition, the quality of the media can be
maintained by media exchange once every 6 hours, during
which time, a pH sensor can determine the pH of the biore
actor. Further, a humidity sensor also can be included in a
MRI-compatible bioreactor system as described herein to
maintain the proper humidity in the bioreactor.
At any time after initiating the culture, at least the tissue
imaging chamber of the bioreactor component can be inserted
into a MR imager and imaged. As discussed herein, the biore
actor component is inserted into the MR imager Such that the
tissue imaging chamber falls within the field-of-view (FOV)
of the MR imager and the support chamber falls outside the
FOV of the MR imager. The biological sample can be imaged
continuously for a period of time (e.g., several milliseconds,
one or more seconds, one or more minutes, or longer) or at
particular intervals (e.g., once every second, once every
minute, multiple times per minute, several times per hour, or
once or multiple times a week). It would be appreciated that
the MRI-compatible bioreactor can be removed from the MR
imager in between imaging, or it can remain inside the imager
even when images are not being obtained.
A biological sample contained within the MRI-compatible
bioreactor system described herein can be imaged once or
multiple times without compromising the sample. That is,
none of the biological sample needs to be removed from the
bioreactor prior to or during imaging, and the components
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6
required for maintaining the viability of the culture are
designed such that they do not interfere with the imaging
process. Thus, the bioreactor remains a "closed’ system, even
when introduced (and re-introduced) into an imager for imag
ing.
As used herein, the biological sample refers to any cell
sample or any tissue sample. Representative cells include,
without limitation, osteoblasts, osteoclasts, osteocytes, chon
drocytes, hepatocytes, islet cells, myocytes, epithelial cells,
kidney cells, and neurons, while representative tissues
include, without limitation, bone, cartilage, liver, pancreas,
muscle, epithelium, kidney, brain, uterus, ovarian, and testes.
Simply by way of example, bone tissue engineering is
emerging as a promising alternative for creating functional
Substitutes for bone repair and replacement. Both autologous
and allogeneic bone grafts are used clinically as bone Substi
tutes; however, the availability of compatible grafts is limited
because harvesting bone is painful and the procedure carries
significant infection risks. Therefore, the MRI-compatible
bioreactor described herein can be used to produce bone
tissue. In addition, as tissue engineering grows in complexity
to match the geometry and function of a patients unique
needs, it becomes increasingly important to non-invasively
follow the spatial and temporal pattern of growth and matu
ration of the bone tissue in vitro. The MRI-compatible biore
actor System described herein is expected to help produce
tissue engineered bone constructs with proper osteogenic
phenotype expression, which can expedite the clinical trans
lation of bone tissue engineered products and improve the
Success rate of bone transplantation.
In accordance with the present invention, there may be
employed conventional molecular biology, microbiology,
biochemical, and recombinant DNA techniques within the
skill of the art. Such techniques are explained fully in the
literature. The invention will be further described in the fol

lowing examples, which do not limit the scope of the methods
and compositions of matter described in the claims.
EXAMPLES
40

Example 1
Design and Configuration of a Prototype e-Incubator
45
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A basic prototype of a MRI-compatible bioreactor has
been developed. Shown in FIG. 1, a cylindrical chamber
system with an outer diameter of 3 cm was designed. Made of
polycarbonate and manufactured by 3D printing, the system
included a Support chamber and a tissue imaging (TI) cham
ber. Tissue samples were positioned atop a permeable Support
inside a tissue holder within the TI chamber. There were many
challenges associated with MRI compatibility when imple
menting the design. For example, in order to truthfully rep
resent the sample's environmental condition, one design
specification requires measuring and adjusting the tempera
ture of the sample's direct surroundings with minimal MR
susceptibility artifacts. Since the TI chamber is inside the
MRI and, therefore, is encompassed by the MRI field-of-view
(FOV), while the support chamber is outside the MRI and the
MRI FOV, the solution used was to place a fiber optic tem
perature probe (SA Instruments, Inc. Stony Brook, N.Y.)
adjacent to the sample in the TI chamber (inside FOV) while
regulating the temperature by an MR compatible ceramic
heater located in the support chamber (outside FOV).
For regulating all environmental conditions inside the TI
chamber for biological samples, a Microchip PIC(R) MCU
was used to operate a closed-loop feedback system via a C

US 9,051,541 B2
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The phantom is tested in the bioreactor for one week,
during which time, the temperature, CO, and humidity
conditions are recorded at a rate of one per ten seconds
and the pH evaluated for every media exchange (sched
uled once every 6 hours). The starting and ending times
of each media exchange are recorded. Used media is
examined under an inverted microscope for contamina
tion. This experiment is repeated twice, and, before
starting the second set of experiments, the bioreactor is

7
program. By integrating both hardware and software, MCUs
are embedded as “brains' in almost all “SMART devices,

from consumer electronics to automobiles to medical sys
tems. Physiological conditions inside the TI chamber were
detected by physical and biochemical sensors and sent to the
MCU. The MCU compared the received sensor signals with
pre-determined thresholds and sent control signals to other
mechatronics to guide their actions for adjusting those con
ditions. For example, the MCU acquired data from the tem
perature, CO., humidity sensors at a rate of one per ten
seconds and the pH was evaluated during every media
exchange. A peristaltic pump was used to exchange media
based on the measured pH level; two flow controllers were
used to mix air and CO to create proper concentration of CO.
for the engineered tissues in the chamber.
A preliminary study on human mesenchymal stem cells
(hMSCs) derived osteogenic construct was performed using
the MRI-compatible bioreactor prototype. For constructs
preparation, human bone MSCs were isolated from fresh
marrow cells provided commercially (Lonza, Walkersville,
Md.). Upon 80% confluence, the hMSCs were trypsinized,
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Verifying the Accuracy of the Operation of the
MRI-Compatible Bioreactor
50

Verifying that such a bioreactor can precisely control the
internal environmental growth conditions for developing tis
sue is required before placing a TE culture inside an MRI

culture, all samples in the conventional incubator are
fixed and undergo similar histological analysis.
All data collected from above experiments, i.e., three sets
of one-week phantom data and three sets of four-week TE
construct data, are analyzed statistically to testify the accu
racy of bioreactor operation:
For each media exchange, the mean time duration required
for temperature, CO, and humidity to return to normal oper
ating mode are computed based on the average difference of
the end and starting times. For all the raw data, data points
recorded during media exchange are filtered and the rest of
the data represents normal operating mode of the bioreactor.
For each physiological parameter in each individual set of
experiment, e.g., temperature, CO level, or humidity, the
mean and standard deviation of measurements during the
normal operating mode are computed.
The following criteria are used to determine if the bioreac
tor performance is adequate.
All of the physiological parameters should return to the
normal operating mode within 5 minutes, which is deter
mined based on the time it takes for a tissue engineer to
exchange the media. The bioreactor is considered satis
factory if the confidence level is at least 95% that, every
time, the duration is less than 5 minutes.
The bioreactor is considered accurate if the confidence

SCa.
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in 1M NaOH for an hour, and then rinsed twice with sterile

water, to eliminate possible contamination.
Two types of biological samples were tested:
Standard culture media as a phantom for verifying the
accuracy of adjusting physiological conditions and
examining possible contamination inside the bioreactor.

neutral buffered formalin and sectioned. This experi
ment is repeated twice as well. In order to confirm the
viability of the TE bone constructs, at the end of each
experiment, sections are stained with hematoxylin and
eosin (H&E) and Von Kossa to examine mineralization
and calcium deposition. In parallel to the experiments
cultured in a conventional incubator. After four weeks of

Example 2

In order to create a reliable environment comparable to a
conventional incubator, targeted operating parameters for the
bioreactor are 37°C., 5% CO level, and 95% relative humid
ity. Regular media exchange is performed for maintaining
proper pH level. Prior to loading biological samples into the
bioreactor, all components are dissembled. All relevant com
ponents inside the TI chamber are cleaned with Alcon, soaked

TE bone constructs for confirming that the e-incubator
provides a Suitable environment for engineered tissues.
ATE osteogenic construct of size 4 mmx4mmx4 mm is
prepared as described in Example 1 and placed inside
the TI chamber for four weeks atop the permeable Sup
port. In addition to recording physiological conditions
as descried above, following four weeks of constructs
culture in the bioreactor, constructs are fixed with 10%

counted, and passaged at a density 5x10 cells/cm and

expanded in vitro. Expanded to passage 4-5, MSCs were
re-Suspended and seeded into gelatin Sponges (Pharmacia &
Upjohn, Kalamazoo, Mich.). Osteogenic medium (Xu et al.,
2006, Phys. Med. Biol., 51:719-32) was used to induce osteo
genesis in the construct. FIG. 2 presents the data from this
study. The viability and growth of the construct was validated
with MRI results: lower signal intensity in construct at
Week-2 compared to Week-1, Suggesting increased mineral
ization and development of bone-like tissue FIG. 2(c) vs.
FIG. 2(b). FIG. 2(d) shows automatic adjustments of the
temperature (between 36 to 37°C.) and CO, level (5%) in the
construct’s Surroundings.
As described herein, the MRI-compatible bioreactor pro
totype was integrated with a high resolution MRI scanner and
TE bone constructs were successfully cultured for two weeks.
The following Examples demonstrate that such a bioreactor
can provide accurate controls to maintain the proper physi
ological environment that is comparable to a conventional
CO incubator. In addition, the following Examples demon
strate that such a bioreactor truly is MRI compatible and
enables prolonged growth (e.g., bone construct growth) to be
continuously and non-invasively monitored.

dissembled, cleaned, reset, and filled with fresh standard
culture media.

65

level is at least 95% that every temperature measurement
is within 1% of 37°C., and every CO/humidity mea
surement is within 5% of its respective target.
For each individual parameter, the means and standard
deviations of one-week phantom are compared to those
of four-week TE constructs to determine if there is sig
nificant difference with respect to the biological sample
and the length of time it is cultured in the bioreactor.
Histological review of TE constructs cultured both in the
bioreactor and the conventional incubator are performed
in a blinded study by a Board-certified pathologist for
assessing possible variation in construct development
between a conventional incubator and the bioreactor.

All physiological conditions of the tissue sample's Sur
roundings are closely monitored and properly regulated
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autonomously via a closed-loop system. Preliminary studies
indicate that the bioreactor performs better than or at least
comparable to conventional incubators, likely due to reduced
human handling (i.e., transferring the samples in a biosafety
cabinet to perform media exchange is no longer needed).
Example 3
Validating the Ability of the e-Incubator in Culturing
Bone Constructs Using Quantitative MRI

10
constructs is greater than or equal to that of “incubator bone,
(ii) the variance of “e-incubator bone constructs is greater
than or equal to that of “incubator bone, and (iii) the mean
value of “e-incubator” control constructs is different than that

of “incubator control. Histological analysis is used as a
reference to confirm bone formation in TE bone constructs.

10

Using engineered bone, an MRI-compatible bioreactor
facilitates non-invasive high-resolution imaging for the con
tinuous evaluation of the constructs concurrent with in vitro

tissue development.

15

In order to confirm that the bioreactor mechatronics inside

the magnet are MRI-compatible and do not affect MRI sen
sitivity in detecting bone formation, engineered bone con
structs were used. In order to take advantage of the bioreac
tor's capability of culturing tissue samples non-interruptedly,

MRI.

the tissue holder of the bioreactor is revised to include fine

grids so that five samples can be cultured and assessed simul
taneously. Constructs cultured in a conventional incubator are
labeled “incubator group and constructs in the bioreactor are
labeled “e-incubator' group.
Thirty TE bone constructs of size 3 mmx3 mmx3 mm are
prepared with the procedures described in Example 1. On
Day 0, constructs are divided into two groups: twenty five

25

“incubator bone constructs and five “e-incubator bone con
structs. All five “e-incubator bone constructs are loaded in

30

the tissue holder of the bioreactor and then the 3 cm cylindri
cal chamber system is inserted into a 4 cm Millipede radiof
requency (RF) imaging probe of a 9.4T (400 MHz for pro
tons) 89 mm vertical bore MRI scanner (Agilent, Santa Clara,
Calif.), equipped with 100 G/cm maximum triple axis gradi

35

MRI with a conventional incubator; measurements are

acquired only at five discrete time points, i.e., Day 0, 7, 14, 21.
and 28, with five samples at each specific time point. At the
end of tissue culture, i.e., Day 28, five remaining “incubator
samples and all five “e-incubator” samples are fixed and
Subjected to histological analysis. These experiments are
repeated on control constructs prepared only with basic cul
ture media. Because the controls are not expected to develop,
no matter in a conventional or the bioreactor, MRI only is
acquired at specified time points for both “incubator' and
“e-incubator groups.
The effectiveness of the bioreactor on growing osteogenic
constructs inside a MRI scanner is quantified by statistical
analysis. For quantitative MRI analysis, the T relaxation
time is analyzed using a mono-exponential model and
mapped for the entire construct using a custom developed
MATLAB program. Based on preliminary results, the mean
value of the T in bone constructs is expected to exhibit a
greater than 50% reduction after 4 weeks in culture, while the
control constructs show no significant difference in T with
time (Xu et al., 2006, Phys. Med. Biol., 51:719-32). The
bioreactor is validated when statistical tests on T. reject the
hypotheses that (i) the mean value of “e-incubator bone

It is to be understood that, while the methods and compo
sitions of matter have been described herein in conjunction
with a number of different aspects, the foregoing description
of the various aspects is intended to illustrate and not limit the
scope of the methods and compositions of matter. Other
aspects, advantages, and modifications are within the scope of
the following claims.
Disclosed are methods and compositions that can be used
for, can be used in conjunction with, can be used in prepara
tion for, or are products of the disclosed methods and com
positions. These and other materials are disclosed herein, and
it is understood that combinations, Subsets, interactions,

ents. The entire construct is divided as six axial slices with a

thickness of 500 um and a spatial resolution of 100 umx100
um. For MRI acquisitions, MR spin-spin relaxation time (T)
is measured by applying a spin echo imaging sequence to
acquire 32 echoes with 4 seconds of repetition time (TR) and
8 milliseconds echo spacing (TE). These measurements are
acquired on a daily basis. For the twenty five “incubator
bone constructs, TE samples are allocated into a test tube and
subjected to MRI. Since it is not possible to perform daily

The use of a detailed imaging assessment technique pro
vided by MRI-integrated bioreactor will allow the production
of high quality TE constructs, to thereby improve the Success
rate of bone replacement implantation. In some instances, the
bioreactor would only be placed inside the magnetic field
during MRI sessions, since the effect of a strong magnetic
field on engineered tissues growth is not well understood.
Also, recent advances such as Zero echo time MRI may be
useful, for example, to study late growth stages of osteogen
esis, since intensive mineralization may hamper conventional

40

groups, etc. of these methods and compositions are disclosed.
That is, while specific reference to each various individual
and collective combinations and permutations of these com
positions and methods may not be explicitly disclosed, each is
specifically contemplated and described herein. For example,
if a particular composition of matter or a particular method is
disclosed and discussed and a number of compositions or
methods are discussed, each and every combination and per
mutation of the compositions and the methods are specifically
contemplated unless specifically indicated to the contrary.
Likewise, any Subset or combination of these is also specifi
cally contemplated and disclosed.
What is claimed is:

45
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1. An MRI-compatible bioreactor System, comprising:
a bioreactor comprising a tissue-imaging chamber and a
Support chamber that are separated by a permeable Sup
port that allows for fluid communication between the
chambers, wherein at least the tissue-imaging chamber
of the bioreactor component is configured to be received
within a magnetic resonance (MR) imager;
wherein the tissue-imaging chamber comprises at least one
fiber optic sensor and fluidics capable of fluidly commu
nicating with a source of oxygen, wherein the tissue
imaging chamber is configured to fall within the field
of-view (FOV) of the MR imager; and
wherein the Support chamber comprises a heating element
and fluidics capable of fluidly communicating with at
least one reservoir, wherein the Support chamber is con
figured to comprise culture media and maintain the cul
ture media under Suitable conditions, wherein the Sup
port chamber is configured to fall outside of the FOV of
the MR imager.
2. The bioreactor system of claim 1, wherein the at least
one fiber optic sensor is a temperature sensor.
3. The bioreactor system of claim 1, further comprising a
microcontroller in communication with the at least one fiber

optic sensor.
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4. The bioreactor System of claim 1, further comprising a
microcontroller in communication with the heater.

5. The bioreactor system of claim 1, further comprising a
microcontroller in communication with the at least one fiber

optic sensor and the heater, wherein the at least one fiber optic
sensor is a temperature sensor.
6. The bioreactor system of claim 1, wherein the support
chamber further comprises at least one non-fiber optic sensor.
7. The bioreactor system of claim 6, wherein the at least
one non-fiber optic sensor is selected from the group consist
ing of a temperature sensor and a pH sensor.
8. The bioreactor system of claim 6, wherein the at least
one non-fiber optic sensor is in communication with a micro
controller.

9. The bioreactor system of claim 1, further comprising a
pump configured to promote fluid communication between
the at least one reservoir and culture media in the Support

5
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chamber.

the bioreactor.

14. The method of claim 12, wherein repeating the insert
ing and the imaging steps at least twice does not compromise
the biological sample or the culture media.
15. The method of claim 10, further comprising repeating
the imaging step at least twice, wherein the inserting step is
performed only once.
16. The method of claim 10, further comprising exchang
ing the media in the support chamber with fresh media in the
at least one reservoir via the fluidics.

10. A method of imaging a biological sample, comprising:
providing the MRI-compatible bioreactor system of claim
1, wherein the tissue imaging chamber comprises a bio
logical sample and the Support chamber comprises cul

17. The method of claim 16, further comprising repeating
the exchanging step at least twice separated by a period of
time.

ture media;

inserting at least the tissue imaging chamber of the biore
actor component into a MR imager Such that the tissue
imaging chamber falls within the field-of-view (FOV) of
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the MR imager and the support chamber does not fall
within the FOV of the MR imager; and
imaging the biological sample using the MR imager.
11. The method of claim 10, wherein the biological sample
is a tissue sample or a cell sample.
12. The method of claim 10, further comprising repeating
the inserting and imaging steps at least twice.
13. The method of claim 12, wherein repeating the insert
ing and the imaging steps at least twice does not require
removing the biological sample or any portion thereof from
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18. The method of claim 17, wherein the period of time is
selected from the group consisting of hours, days, weeks, and
months.

